Based in Israel’s Caesarea Industrial Park, Itamar Medical Ltd. (TASE:ITMR) is a publicly traded medical device company that develops non-invasive medical devices using the Company’s proprietary platform technology, the PAT™ (Peripheral Arterial Tone) signal. The company currently markets the WatchPAT™ home sleep test for respiratory sleep disorder diagnosis, and the EndoPAT™, the only device approved by the U.S. FDA for testing endothelial (arterial) function and assessing the risk of coronary artery disease and other cardiovascular diseases.
Founded in 1998 by Peretz Lavie and Giora Yaron.
CEO: Gilad Glick (pictured)
Go To Site
